Cargando…

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Detalles Bibliográficos
Autores principales:	Tomelleri, Alessandro, Sartorelli, Silvia, Campochiaro, Corrado, Baldissera, Elena Marina, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456557/ https://www.ncbi.nlm.nih.gov/pubmed/32345617 http://dx.doi.org/10.1136/annrheumdis-2020-217600

Ejemplares similares

A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)
por: Campochiaro, Corrado, et al.
Publicado: (2021)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

Adult-onset Still’s disease complicated by Guillain-Barré syndrome
por: Farina, Nicola, et al.
Publicado: (2023)

Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India
por: Misra, Durga Prasanna, et al.
Publicado: (2022)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
por: Cavalli, Giulio, et al.
Publicado: (2020)

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease
por: Tomelleri, Alessandro, et al.
Publicado: (2018)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Large vessel vasculitis
por: Gulati, Ashima, et al.
Publicado: (2009)

Multimodal Chorioretinal Imaging in Erdheim-Chester Disease
por: Sacconi, Riccardo, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction
por: Palmisano, Anna, et al.
Publicado: (2023)

Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: Differences between first and second Italian pandemic wave
por: Palumbo, Diego, et al.
Publicado: (2021)

Pericarditis Revealing Large Vessel Vasculitis
por: Couturier, Bruno, et al.
Publicado: (2011)

An Unusual Case of Large-Vessel Vasculitis
por: Alsaed, Omar Suhail, et al.
Publicado: (2018)

Vasculitogenic T Cells in Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Large Vessel Vasculitis with Chronic Cough
por: Okumura, Hisatoshi, et al.
Publicado: (2023)

Novel Angiographic Scores for evaluation of Large Vessel Vasculitis
por: Tombetti, Enrico, et al.
Publicado: (2018)

The utility of PET/CT in large vessel vasculitis
por: Ben Shimol, Jennifer, et al.
Publicado: (2020)

Perspectives of JAK Inhibitors for Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Vessel inflammation and morphological changes in patients with large vessel vasculitis: a retrospective study
por: Besutti, Giulia, et al.
Publicado: (2022)

Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)

Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome
por: Yabe, Hiroki
Publicado: (2018)

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2020)

Immunomodulatory role of Interleukin-33 in large vessel vasculitis
por: Desbois, Anne-Claire, et al.
Publicado: (2020)

Peripheral Ulcerative Keratitis Associated With Large Vessel Vasculitis
por: Uchida, Shun, et al.
Publicado: (2021)

Pathogenic role of monocytes/macrophages in large vessel vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Large-vessel Vasculitis of Extremities without Aortic Involvement
por: Ito, Takanori, et al.
Publicado: (2021)

Animal models for large vessel vasculitis – The unmet need
por: Chu, Cong-Qiu
Publicado: (2023)

Erdheim–Chester disease presenting as large vessel vasculitis
por: Ahmed, Azeem, et al.
Publicado: (2023)

PB2199: GEOGRAPHIC CLUSTERING OF ERDHEIM-CHESTER DISEASE IN ITALY AND FRANCE
por: Peyronel, Francesco, et al.
Publicado: (2023)

Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study
por: Coattrenec, Yann, et al.
Publicado: (2021)

Myocarditis: An Interleukin-1-Mediated Disease?
por: De Luca, Giacomo, et al.
Publicado: (2018)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
por: Michailidou, Despina, et al.
Publicado: (2022)

Varicella Zoster Virus and Large Vessel Vasculitis, the Absence of an Association
por: Procop, Gary W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4dsmom291mkcgviul7af0ns3f2